February 8, 2018 / 7:06 AM / 10 months ago

BRIEF-Shionogi says ViiV Healthcare files patent infringement litigation against Gilead Sciences over bictegravir

Feb 8 (Reuters) - Shionogi & Co Ltd

* Says it announced that ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, has filed patent infringement litigation against Gilead Sciences Inc. over bictegravir in the United States and Canada

* The United States case is filed in the U.S. District Court for the District of Delaware and the patent is U.S patent No. 8,129,385

* The Canadian case is filed in the Canadian Federal Court in Toronto and the patent is Canadian Patent No. 2,606,282.

Source text in Japanese:goo.gl/A6JmYz

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below